NASDAQ: LRMR

Larimar Therapeutics Inc Stock Forecast, Predictions & Price Target

The consensus among 3 Wall Street analysts covering (NASDAQ: LRMR) stock is to Strong Buy LRMR stock.

Out of 3 analysts, 1 (33.33%) are recommending LRMR as a Strong Buy, 2 (66.67%) are recommending LRMR as a Buy, 0 (0%) are recommending LRMR as a Hold, 0 (0%) are recommending LRMR as a Sell, and 0 (0%) are recommending LRMR as a Strong Sell.

If you're new to stock investing, here's how to buy Larimar Therapeutics stock.

(NASDAQ: LRMR) Larimar Therapeutics's forecast annual revenue growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 38.32%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 10.27%.

Larimar Therapeutics's revenue in 2024 is $0.On average, 1 Wall Street analysts forecast LRMR's revenue for 2026 to be $2,788,060,743, with the lowest LRMR revenue forecast at $2,788,060,743, and the highest LRMR revenue forecast at $2,788,060,743. On average, 1 Wall Street analysts forecast LRMR's revenue for 2027 to be $6,290,681,676, with the lowest LRMR revenue forecast at $6,290,681,676, and the highest LRMR revenue forecast at $6,290,681,676.

In 2028, LRMR is forecast to generate $13,008,823,466 in revenue, with the lowest revenue forecast at $13,008,823,466 and the highest revenue forecast at $13,008,823,466.

According to 3 Wall Street analysts that have issued a 1 year LRMR price target, the average LRMR price target is $20.00, with the highest LRMR stock price forecast at $25.00 and the lowest LRMR stock price forecast at $10.00.

On average, Wall Street analysts predict that Larimar Therapeutics's share price could reach $20.00 by Apr 3, 2025. The average Larimar Therapeutics stock price prediction forecasts a potential upside of 183.69% from the current LRMR share price of $7.05.

(NASDAQ: LRMR) forecast ROE is N/A, which is considered weak.